Balance Sheet Account Details

6 Months Ended

Jun. 30, 2020

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Balance Sheet Account Details

Balance Sheet Details

Restricted Cash

Restricted cash as of June 30, 2020 and December 31, 2019 represents a standby letter of credit for the Company’s building lease in lieu of a security deposit during the term of such lease (see Note 6). There is a requirement to maintain $0.6 million of cash collateral in an account pledged as security for such letter of credit.

Inventory, Net

Inventory, net consisted of the following (in thousands):

	June 30, 2020		December 31, 2019
Work-in-process	$	1,801	$	1,505
Finished goods	1,319		706
Total inventory, net	$	3,120	$	2,211

As of June 30, 2020 and December 31, 2019, total inventory is recorded net of inventory reserves of $0.2 million and $0.1 million, respectively.

Property and Equipment, Net

Property and equipment, net consisted of the following (in thousands):

	June 30, 2020			December 31, 2019
Leasehold improvements	$	14,504		$	14,504
Furniture and fixtures	2,549			2,598
Computer hardware	1,296			1,296
Software	733			733
Lab equipment	—			9,665
Total property and equipment, gross	19,082			28,796
Accumulated depreciation and amortization	(6,255		)	(10,407		)
Total property and equipment, net	$	12,827		$	18,389

Accrued Expenses

Accrued expenses consisted of the following (in thousands):

	June 30, 2020		December 31, 2019
Accrued interest expense	$	3,530	$	2,692
Accrued manufacturing costs	1,369		1,339
Accrued clinical study costs	815		3,496
Accrued other	1,058		1,785
Total accrued expenses	$	6,772	$	9,312